Aug 16, 2018 05:02 PM IST
Motilal Oswal is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 481 in its research report dated August 08, 2018.
- Aug 10, 2018 04:43 PM IST
HDFC Securities is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 480 in its research report dated 09 Aug 2018.
- Jul 04, 2018 09:49 AM IST
- Jul 03, 2018 09:50 AM IST
Ibuprofen is used to relieve pain from various conditions such as headache, dental pain, muscle aches, or arthritis.
- Jun 21, 2018 07:25 PM IST
Strides Shasun has received pre-qualification from the World Health Organization (WHO) for its rectal artesunate product for the pre-referral management of severe malaria.
- May 29, 2018 11:38 AM IST
In November 2015, Strides Arcolab had changed its name to Strides Shasun post amalgamation of Shasun Pharmaceuticals with Strides Arcolab.
- May 25, 2018 04:38 PM IST
JM Financial is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 530 in its research report dated May 21, 2018.
- May 21, 2018 06:10 PM IST
HDFC Securities is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 980 in its research report dated May 10, 2018.
- May 18, 2018 03:25 PM IST
The most actively traded stocks on the NSE were Bajaj Finance, up over 4 percent, and Reliance Communications, which plunged over 10 percent.
- May 18, 2018 03:05 PM IST
Revenue from operations fell by 1.9 percent year-on-year to Rs 664.2 crore for the quarter ended March 2018.
- May 18, 2018 02:06 PM IST
Other income during the quarter fell sharply to Rs 21.8 crore compared to Rs 62.4 crore in Q4FY17.
- Apr 24, 2018 04:20 PM IST
The company's board today approved divestment of its 100 per cent shareholding in Strides Chemicals to Solara, Strides Shasun said in a regulatory filing.
- Apr 12, 2018 12:27 PM IST
Cyproheptadine hydrochloride tablets is a generic version of Periactin tablets of Merck & Co Inc.
- Apr 11, 2018 03:05 PM IST
"The company’s market share in Q3FY18 quarter was 33 percent, which is up 6 percent points compared to what it reported last quarter," Akash Jain, Vice-president, Equity Research at Ajcon Global Services.
- Apr 02, 2018 02:16 PM IST
The company's wholly-owned subsidiary Strides Pharma Global has received approval for Ibuprofen capsules in the strength of 200 mg from the United States Food & Drug Administration (USFDA), Strides Shasun said in a statement.
- Mar 16, 2018 08:40 AM IST
"Till Nifty holds 10,350 levels decisively, bounce back from lower levels cannot be ruled out and on higher end stiff hurdle seen around 10,490 mark," says Rajesh Agarwal of AUM Capital.
- Mar 14, 2018 01:25 PM IST
The approval granted to the company's wholly-owned subsidiary Strides Pharma Global Pte by the US Food and Drug Administration (USFDA) is for Efavirenz tablets of 600 mg strength, the company said in a regulatory filing.
- Feb 26, 2018 11:55 AM IST
Strides is already a key player in the US Ranitidine Rx market with 32 per cent market share through its approval for Ranitidine Tablets USP, 150 mg and 300 mg. The new launch will further strengthen company’s Ranitidine franchise, the company said in a statement.
- Feb 22, 2018 08:34 AM IST
Ashwani Gujral of ashwanigujral.com recommends buying Tech Mahindra with a stop loss of Rs 588, target of Rs 620, a buy on NIIT Tech with a stop loss of Rs 788, target of Rs 825 while a sell call on Century Textiles with a stop loss of Rs 1190, target of Rs 1130.
- Jan 29, 2018 11:51 AM IST
In a BSE filing, it said Strides Pharma Global Pte. has received approval from the United States Food and Drug Administration (USFDA) for tenofovir disoproxil fumarate tablets, 300 mg.
- Jan 23, 2018 01:02 PM IST
Most experts are calling this to be a pre-budget rally and the euphoria is tied up to the Budget, and thankfully the December quarter earnings have not been bad in fact some of them were better than estimates.
- Jan 10, 2018 09:36 AM IST
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Reliance Industries, Torrent Power and Strides Shasun and can sell Union Bank of India.
- Dec 20, 2017 05:41 PM IST
The transaction provides access to pipeline of more than 110 product dossiers already submitted in addition to an important platform for Strides' ARV launch in the large, prive non-tender market in South Africa.
- Dec 20, 2017 12:51 PM IST
"Strides Pharma Asia Pte, Singapore, a wholly-owned subsidiary of Strides Shasun has entered into definitive agreements with Trinity Pharma Proprietary, South Africa for acquisition of controlling stake in Trinity," Strides Shasun said in a BSE filing.
- Nov 21, 2017 06:22 PM IST
HDFC Securities is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1200 in its research report dated 21 November 2017.